Global and United States Pandemic Influenza Vaccine Market Insights, Forecast to 2026

Publisher Name :
Date: 15-Oct-2020
No. of pages: 126
Inquire Before Buying

Pandemic Influenza Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pandemic Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Pandemic Influenza Vaccine market is segmented into

Influenza A (H1N1) Vaccines

Other

Segment by Application, the Pandemic Influenza Vaccine market is segmented into

Adult

Paediatric

Regional and Country-level Analysis

The Pandemic Influenza Vaccine market is analysed and market size information is provided by regions (countries).

The key regions covered in the Pandemic Influenza Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Pandemic Influenza Vaccine Market Share Analysis

Pandemic Influenza Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pandemic Influenza Vaccine business, the date to enter into the Pandemic Influenza Vaccine market, Pandemic Influenza Vaccine product introduction, recent developments, etc.

The major vendors covered:

AstraZeneca

GlaxoSmithKline

Novartis

Sanofi

Valneva

Lupin

Chiron Panacea

Solvay and Serum Institute of India Pvt. Ltd.

Sementis

Global and United States Pandemic Influenza Vaccine Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pandemic Influenza Vaccine Product Introduction
1.2 Market Segments
1.3 Key Pandemic Influenza Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Type
1.4.2 Influenza A (H1N1) Vaccines
1.4.3 Other
1.5 Market by Application
1.5.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Application
1.5.2 Adult
1.5.3 Paediatric
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pandemic Influenza Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Pandemic Influenza Vaccine Revenue 2015-2026
2.1.2 Global Pandemic Influenza Vaccine Sales 2015-2026
2.2 Global Pandemic Influenza Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Pandemic Influenza Vaccine Historical Market Size by Region (2015-2020)
2.3.1 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Pandemic Influenza Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Pandemic Influenza Vaccine Sales Forecast by Region (2021-2026)
2.4.2 Global Pandemic Influenza Vaccine Revenue Forecast by Region (2021-2026)
3 Global Pandemic Influenza Vaccine Competitor Landscape by Players
3.1 Global Top Pandemic Influenza Vaccine Sales by Manufacturers
3.1.1 Global Pandemic Influenza Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Global Pandemic Influenza Vaccine Manufacturers by Revenue
3.2.1 Global Pandemic Influenza Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Pandemic Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pandemic Influenza Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pandemic Influenza Vaccine Revenue in 2019
3.2.5 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pandemic Influenza Vaccine Price by Manufacturers
3.4 Global Pandemic Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pandemic Influenza Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pandemic Influenza Vaccine Market Size by Type (2015-2020)
4.1.1 Global Pandemic Influenza Vaccine Sales by Type (2015-2020)
4.1.2 Global Pandemic Influenza Vaccine Revenue by Type (2015-2020)
4.1.3 Pandemic Influenza Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pandemic Influenza Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Pandemic Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pandemic Influenza Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pandemic Influenza Vaccine Market Size by Application (2015-2020)
5.1.1 Global Pandemic Influenza Vaccine Sales by Application (2015-2020)
5.1.2 Global Pandemic Influenza Vaccine Revenue by Application (2015-2020)
5.1.3 Pandemic Influenza Vaccine Price by Application (2015-2020)
5.2 Pandemic Influenza Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pandemic Influenza Vaccine Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Pandemic Influenza Vaccine Market Size YoY Growth 2015-2026
6.1.1 United States Pandemic Influenza Vaccine Sales YoY Growth 2015-2026
6.1.2 United States Pandemic Influenza Vaccine Revenue YoY Growth 2015-2026
6.1.3 United States Pandemic Influenza Vaccine Market Share in Global Market 2015-2026
6.2 United States Pandemic Influenza Vaccine Market Size by Players (International and Local Players)
6.2.1 United States Top Pandemic Influenza Vaccine Players by Sales (2015-2020)
6.2.2 United States Top Pandemic Influenza Vaccine Players by Revenue (2015-2020)
6.3 United States Pandemic Influenza Vaccine Historic Market Review by Type (2015-2020)
6.3.1 United States Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
6.3.2 United States Pandemic Influenza Vaccine Revenue Market Share by Type (2015-2020)
6.3.3 United States Pandemic Influenza Vaccine Price by Type (2015-2020)
6.4 United States Pandemic Influenza Vaccine Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Pandemic Influenza Vaccine Sales Forecast by Type (2021-2026)
6.4.2 United States Pandemic Influenza Vaccine Revenue Forecast by Type (2021-2026)
6.4.3 United States Pandemic Influenza Vaccine Price Forecast by Type (2021-2026)
6.5 United States Pandemic Influenza Vaccine Historic Market Review by Application (2015-2020)
6.5.1 United States Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
6.5.2 United States Pandemic Influenza Vaccine Revenue Market Share by Application (2015-2020)
6.5.3 United States Pandemic Influenza Vaccine Price by Application (2015-2020)
6.6 United States Pandemic Influenza Vaccine Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Pandemic Influenza Vaccine Sales Forecast by Application (2021-2026)
6.6.2 United States Pandemic Influenza Vaccine Revenue Forecast by Application (2021-2026)
6.6.3 United States Pandemic Influenza Vaccine Price Forecast by Application (2021-2026)
7 North America
7.1 North America Pandemic Influenza Vaccine Market Size YoY Growth 2015-2026
7.2 North America Pandemic Influenza Vaccine Market Facts & Figures by Country
7.2.1 North America Pandemic Influenza Vaccine Sales by Country (2015-2020)
7.2.2 North America Pandemic Influenza Vaccine Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Pandemic Influenza Vaccine Market Size YoY Growth 2015-2026
8.2 Europe Pandemic Influenza Vaccine Market Facts & Figures by Country
8.2.1 Europe Pandemic Influenza Vaccine Sales by Country
8.2.2 Europe Pandemic Influenza Vaccine Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Pandemic Influenza Vaccine Market Size YoY Growth 2015-2026
9.2 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Country
9.2.1 Asia Pacific Pandemic Influenza Vaccine Sales by Region (2015-2020)
9.2.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Pandemic Influenza Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Pandemic Influenza Vaccine Market Facts & Figures by Country
10.2.1 Latin America Pandemic Influenza Vaccine Sales by Country
10.2.2 Latin America Pandemic Influenza Vaccine Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pandemic Influenza Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Country
11.2.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
12.1.5 AstraZeneca Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Description and Business Overview
12.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline Pandemic Influenza Vaccine Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Description and Business Overview
12.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Pandemic Influenza Vaccine Products Offered
12.3.5 Novartis Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Description and Business Overview
12.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Pandemic Influenza Vaccine Products Offered
12.4.5 Sanofi Recent Development
12.5 Valneva
12.5.1 Valneva Corporation Information
12.5.2 Valneva Description and Business Overview
12.5.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Valneva Pandemic Influenza Vaccine Products Offered
12.5.5 Valneva Recent Development
12.6 Lupin
12.6.1 Lupin Corporation Information
12.6.2 Lupin Description and Business Overview
12.6.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Lupin Pandemic Influenza Vaccine Products Offered
12.6.5 Lupin Recent Development
12.7 Chiron Panacea
12.7.1 Chiron Panacea Corporation Information
12.7.2 Chiron Panacea Description and Business Overview
12.7.3 Chiron Panacea Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Chiron Panacea Pandemic Influenza Vaccine Products Offered
12.7.5 Chiron Panacea Recent Development
12.8 Solvay and Serum Institute of India Pvt. Ltd.
12.8.1 Solvay and Serum Institute of India Pvt. Ltd. Corporation Information
12.8.2 Solvay and Serum Institute of India Pvt. Ltd. Description and Business Overview
12.8.3 Solvay and Serum Institute of India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Products Offered
12.8.5 Solvay and Serum Institute of India Pvt. Ltd. Recent Development
12.9 Sementis
12.9.1 Sementis Corporation Information
12.9.2 Sementis Description and Business Overview
12.9.3 Sementis Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sementis Pandemic Influenza Vaccine Products Offered
12.9.5 Sementis Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.11.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
12.11.5 AstraZeneca Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pandemic Influenza Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pandemic Influenza Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Pandemic Influenza Vaccine Market Segments
Table 2. Ranking of Global Top Pandemic Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pandemic Influenza Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Influenza A (H1N1) Vaccines
Table 5. Major Manufacturers of Other
Table 6. Global Pandemic Influenza Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 7. Global Pandemic Influenza Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 8. Global Pandemic Influenza Vaccine Sales by Regions 2015-2020 (K Doses)
Table 9. Global Pandemic Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 10. Global Pandemic Influenza Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Pandemic Influenza Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 12. Global Pandemic Influenza Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 13. Global Pandemic Influenza Vaccine Sales Share by Manufacturers (2015-2020)
Table 14. Global Pandemic Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pandemic Influenza Vaccine as of 2019)
Table 16. Pandemic Influenza Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Pandemic Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Pandemic Influenza Vaccine Price (2015-2020) (USD/Dose)
Table 19. Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Pandemic Influenza Vaccine Product Type
Table 21. Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 24. Global Pandemic Influenza Vaccine Sales Share by Type (2015-2020)
Table 25. Global Pandemic Influenza Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Pandemic Influenza Vaccine Revenue Share by Type (2015-2020)
Table 27. Pandemic Influenza Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 28. Global Pandemic Influenza Vaccine Sales Share by Type (2021-2026)
Table 29. Global Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 30. Global Pandemic Influenza Vaccine Sales Share by Application (2015-2020)
Table 31. Global Pandemic Influenza Vaccine Sales Share by Application (2021-2026)
Table 32. Global Pandemic Influenza Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Pandemic Influenza Vaccine Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Pandemic Influenza Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 35. United States Pandemic Influenza Vaccine Sales (K Doses) of Key Companies (2015-2020)
Table 36. United States Pandemic Influenza Vaccine Sales Share by Company (2015-2020)
Table 37. United States Pandemic Influenza Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 38. United States Pandemic Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 39. United States Pandemic Influenza Vaccine Sales Share by Type (2015-2020)
Table 40. United States Pandemic Influenza Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. United States Pandemic Influenza Vaccine Price (K Doses) by Type (2015-2020)
Table 42. United States Pandemic Influenza Vaccine Sales (K Doses) by Type (2021-2026)
Table 43. United States Pandemic Influenza Vaccine Sales Share by Type (2021-2026)
Table 44. United States Pandemic Influenza Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. United States Pandemic Influenza Vaccine Revenue Share by Type (2021-2026)
Table 46. United States Pandemic Influenza Vaccine Price (K Doses) by Type (2021-2026)
Table 47. United States Pandemic Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 48. United States Pandemic Influenza Vaccine Sales Share by Application (2015-2020)
Table 49. United States Pandemic Influenza Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. United States Pandemic Influenza Vaccine Sales (K Doses) by Application (2021-2026)
Table 51. United States Pandemic Influenza Vaccine Sales Share by Application (2021-2026)
Table 52. United States Pandemic Influenza Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. United States Pandemic Influenza Vaccine Revenue Share by Application (2021-2026)
Table 54. North America Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 55. North America Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 56. North America Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 58. Europe Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 59. Europe Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 60. Europe Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Pandemic Influenza Vaccine Sales by Region (2015-2020) (K Doses)
Table 63. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Region (2015-2020)
Table 66. Latin America Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 67. Latin America Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 71. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 74. AstraZeneca Corporation Information
Table 75. AstraZeneca Description and Business Overview
Table 76. AstraZeneca Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. AstraZeneca Pandemic Influenza Vaccine Product
Table 78. AstraZeneca Recent Development
Table 79. GlaxoSmithKline Corporation Information
Table 80. GlaxoSmithKline Description and Business Overview
Table 81. GlaxoSmithKline Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Recent Development
Table 84. Novartis Corporation Information
Table 85. Novartis Description and Business Overview
Table 86. Novartis Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Novartis Product
Table 88. Novartis Recent Development
Table 89. Sanofi Corporation Information
Table 90. Sanofi Description and Business Overview
Table 91. Sanofi Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. Sanofi Product
Table 93. Sanofi Recent Development
Table 94. Valneva Corporation Information
Table 95. Valneva Description and Business Overview
Table 96. Valneva Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Valneva Product
Table 98. Valneva Recent Development
Table 99. Lupin Corporation Information
Table 100. Lupin Description and Business Overview
Table 101. Lupin Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Lupin Product
Table 103. Lupin Recent Development
Table 104. Chiron Panacea Corporation Information
Table 105. Chiron Panacea Description and Business Overview
Table 106. Chiron Panacea Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Chiron Panacea Product
Table 108. Chiron Panacea Recent Development
Table 109. Solvay and Serum Institute of India Pvt. Ltd. Corporation Information
Table 110. Solvay and Serum Institute of India Pvt. Ltd. Description and Business Overview
Table 111. Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Solvay and Serum Institute of India Pvt. Ltd. Product
Table 113. Solvay and Serum Institute of India Pvt. Ltd. Recent Development
Table 114. Sementis Corporation Information
Table 115. Sementis Description and Business Overview
Table 116. Sementis Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Sementis Product
Table 118. Sementis Recent Development
Table 119. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 120. Key Challenges
Table 121. Market Risks
Table 122. Main Points Interviewed from Key Pandemic Influenza Vaccine Players
Table 123. Pandemic Influenza Vaccine Customers List
Table 124. Pandemic Influenza Vaccine Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Pandemic Influenza Vaccine Product Picture
Figure 2. Global Pandemic Influenza Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Influenza A (H1N1) Vaccines Product Picture
Figure 4. Other Product Picture
Figure 5. Global Pandemic Influenza Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Adult
Figure 7. Paediatric
Figure 8. Pandemic Influenza Vaccine Report Years Considered
Figure 9. Global Pandemic Influenza Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Pandemic Influenza Vaccine Sales 2015-2026 (K Doses)
Figure 11. Global Pandemic Influenza Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Pandemic Influenza Vaccine Sales Market Share by Region (2015-2020)
Figure 13. Global Pandemic Influenza Vaccine Sales Market Share by Region in 2019
Figure 14. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2015-2020)
Figure 15. Global Pandemic Influenza Vaccine Revenue Market Share by Region in 2019
Figure 16. Global Pandemic Influenza Vaccine Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Pandemic Influenza Vaccine Revenue in 2019
Figure 18. Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Figure 20. Global Pandemic Influenza Vaccine Sales Market Share by Type in 2019
Figure 21. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2015-2020)
Figure 22. Global Pandemic Influenza Vaccine Revenue Market Share by Type in 2019
Figure 23. Global Pandemic Influenza Vaccine Market Share by Price Range (2015-2020)
Figure 24. Global Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Figure 25. Global Pandemic Influenza Vaccine Sales Market Share by Application in 2019
Figure 26. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2015-2020)
Figure 27. Global Pandemic Influenza Vaccine Revenue Market Share by Application in 2019
Figure 28. United States Pandemic Influenza Vaccine Sales Growth Rate 2015-2026 (K Doses)
Figure 29. United States Pandemic Influenza Vaccine Revenue Growth Rate 2015-2026 (US$ Million)
Figure 30. United States Pandemic Influenza Vaccine Market Share in Global Market 2015-2026
Figure 31. United States 5 and 10 Largest Pandemic Influenza Vaccine Players Market Share by Revenue in Pandemic Influenza Vaccine in 2019
Figure 32. United States Pandemic Influenza Vaccine Revenue Share by Type (2015-2020)
Figure 33. United States Pandemic Influenza Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 34. United States Pandemic Influenza Vaccine Revenue Share by Application (2015-2020)
Figure 35. United States Pandemic Influenza Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 36. North America Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 37. North America Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 39. North America Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 40. U.S. Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 41. U.S. Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Canada Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Europe Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 45. Europe Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 47. Europe Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 48. Germany Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Germany Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 51. France Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 53. U.K. Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 55. Italy Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 57. Russia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Asia Pacific Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 59. Asia Pacific Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region in 2019
Figure 61. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Region in 2019
Figure 62. China Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 63. China Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 65. Japan Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 67. South Korea Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 69. India Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Australia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Taiwan Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Indonesia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Thailand Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Malaysia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Philippines Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 83. Vietnam Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Latin America Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 85. Latin America Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 87. Latin America Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 88. Mexico Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Mexico Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Brazil Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Argentina Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Middle East and Africa Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 95. Middle East and Africa Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 98. Turkey Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 99. Turkey Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Saudi Arabia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 103. U.A.E Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Porter's Five Forces Analysis
Figure 105. Pandemic Influenza Vaccine Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
  • Global 9-valent HPV Vaccine (9vHPV) Market Growth 2020-2025
    Published: 29-Oct-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the 9-valent HPV Vaccine (9vHPV) market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in 9-valent HPV Vaccine (9vHPV) business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of 9-valent HPV Va......
  • Global Wilson's Disease Market Growth (Status and Outlook) 2020-2025
    Published: 29-Oct-2020        Price: US 3660 Onwards        Pages: 136
    According to this study, over the next five years the Wilson's Disease market will register a 4.3%% CAGR in terms of revenue, the global market size will reach $ 228.2 million by 2025, from $ 192.7 million in 2019. In particular, this report presents the global revenue market share of key companies in Wilson's Disease business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Wilson's Disease market by product type, ap......
  • Global Penicillamine Market Growth 2020-2025
    Published: 29-Oct-2020        Price: US 3660 Onwards        Pages: 132
    According to this study, over the next five years the Penicillamine market will register a 1.4%% CAGR in terms of revenue, the global market size will reach $ 88 million by 2025, from $ 83 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Penicillamine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Penicillamine market by product type, applic......
  • Global Dronabinol (CAS 1972-08-3) Market Growth 2020-2025
    Published: 29-Oct-2020        Price: US 3660 Onwards        Pages: 131
    According to this study, over the next five years the Dronabinol (CAS 1972-08-3) market will register a 4.7%% CAGR in terms of revenue, the global market size will reach $ 176.6 million by 2025, from $ 147 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dronabinol (CAS 1972-08-3) business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Dronabinol (CA......
  • Global Chenodeoxycholic Acid Market Growth 2020-2025
    Published: 29-Oct-2020        Price: US 3660 Onwards        Pages: 133
    According to this study, over the next five years the Chenodeoxycholic Acid market will register a 6.2%% CAGR in terms of revenue, the global market size will reach $ 433.4 million by 2025, from $ 340.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Chenodeoxycholic Acid business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Chenodeoxycholic Acid ......
  • Global Autoimmunity Reagents Market Growth 2020-2025
    Published: 29-Oct-2020        Price: US 3660 Onwards        Pages: 162
    According to this study, over the next five years the Autoimmunity Reagents market will register a 9.3%% CAGR in terms of revenue, the global market size will reach $ 1960.2 million by 2025, from $ 1372.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Autoimmunity Reagents business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmunity Reagent......
  • Global and China Anti-Suicide Drug Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 134
    Anti-Suicide Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Suicide Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Anti-Suicide Drug market is segmented......
  • Global and United States Animal Generic Drug Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 143
    Animal Generic Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Animal Generic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Animal Generic Drug market is seg......
  • Global and China Contrast Agents for Magnetic Resonance Imaging (MRI) Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 147
    Contrast Agents for Magnetic Resonance Imaging (MRI) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Contrast Agents for Magnetic Resonance Imaging (MRI) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs